Eniko R. Toke
Veszprem, VE, Hungary
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
T cell immunity ameliorates COVID-19 disease severity and provides post-exposure prophylaxis after peptide-vaccination, in Syrian hamsters.
Journal: Frontiers in immunology
Published: November 29, 2022
Safety and Activity of PolyPEPI1018 Combined with Maintenance Therapy in Metastatic Colorectal Cancer: an Open-Label, Multicenter, Phase Ib Study.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 14, 2022
In Silico Model Estimates the Clinical Trial Outcome of Cancer Vaccines.
Journal: Cells
Published: September 29, 2021
A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent Subjects.
Journal: Frontiers in genetics
Published: March 22, 2021
In vivo study of targeted nanomedicine delivery into Langerhans cells by multiphoton laser scanning microscopy.
Journal: Experimental dermatology
Published: June 03, 2014
Exploitation of Langerhans cells for in vivo DNA vaccine delivery into the lymph nodes.
Journal: Gene therapy
Published: September 15, 2013
DermAll nanomedicine for allergen-specific immunotherapy.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: December 27, 2012
Collision-induced dissociation study of poly(2-ethyl-2-oxazoline) using survival yields and breakdown curves.
Journal: Journal of mass spectrometry : JMS
Published: July 18, 2012
Nanomedicine applications towards the cure of HIV.
Journal: Nanomedicine : nanotechnology, biology, and medicine
Published: February 10, 2012
Single DermaVir immunization: dose-dependent expansion of precursor/memory T cells against all HIV antigens in HIV-1 infected individuals.
Journal: PloS one
Published: January 10, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026